Article Sidebar

Submitted
October 17, 2023
Accepted
November 28, 2024
Published
January 2, 2025
Download
PDF
Statistic
Read Counter : 23 Download : 12

Downloads

Download data is not yet available.

Main Article Content

Abstract

Background: The manifestation of dengue is a decrease in hematocrit and platelet levels, leading to a decrease in the patient’s quality of life and having an impact on the patient’s medical costs.
Objective: This study objective was to ascertain the quality of life and medical costs associated with dengue patients.
Method: This study employed a cross-sectional design at PKU Muhammadiyah Hospitals in Bantul and Yogyakarta from January to August in 2023. Pediatric patients’ quality of life was assessed using the EQ-5D-Y questionnaire, while adult patients’ using the EQ-5D-5L questionnaire. Data on patients’ medical costs was obtained from the hospital's financial database. The data were then analyzed descriptively and presented as a percentage of quality of life and average medical costs.
Results: The results showed that pediatric DF patients in both hospitals reported anxiety and depression, with percentages of 100% (Yogyakarta) and 75% (Bantul), respectively. Meanwhile, most adult DF patients experienced problems in carrying out routines, 71.4% (Yogyakarta) and 50% (Bantul), respectively. Adult DHF patients in both hospitals reported pain and discomfort of 66.7% (Yogyakarta) and 100% (Bantul), respectively. The highest average medical costs paid by DF and DHF patients at PKU Jogja Hospital were IDR 4,919,450 and IDR 6,981,500. DF and DHF patients at PKU Hospital with BPJS insurance, with the highest average medical costs of IDR 2,726,245.5 (for DF patients) and IDR 4,797,700 (for DHF patients) to cover for laboratory costs.
Conclusion: Dengue fever infections are impacting the patient's quality of life and medical costs.

Keywords

Dengue medical costs quality of life

Article Details

License
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish in the Jurnal Ilmiah Farmasi agree to the following terms:

  1. Authors retain copyright and grant Jurnal Ilmiah Farmasi right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Ilmiah Farmasi.
  2. Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Ilmiah Farmasi.
Crossref
Scopus
Google Scholar
Europe PMC

References

  1. Amini, N. H., Hartoyo, E., & Rahmiati. (2019). Hubungan Hematokrit dan Jumlah Trombosit Terhadap Lama Rawat Inap Pasien DBD Anak Di RSUD Ulin Banjarmasin. Jurnal Homeostasis, 2(3), 407–416.
  2. Carrington L.B. & Simmons C.P. (2014). Human to Mosquito Transmission of Dengue Viruses. Frontiers in Immunology, 17(5), 1-8. https://doi.org/10.3389/fimmu.2014.00290.
  3. Dinkes DIY. (2021). Profil Kesehatan D.I. Yogyakarta Tahun 2020. Dinas Kesehatan Provinsi Daerah Istimewa Yogtakarta. Yogyakarta: Dinas Kesehatan Daerah Istimewa Yogyakarta.
  4. Dwi, R., Dan, W., & Sabir, M. (2011). Karakteristik Penderita Demam Berdarah Dengue (DBD) di Rumah Sakit Wahidin Sudirohusodo Makassar Periode Januari-Desember 2010. Inspirasi, 1(14), 1-24.
  5. Halasa, Y. A., Shepard, D. S., & Zeng, W. (2012). Economic cost of dengue in Puerto Rico. American Journal of Tropical Medicine and Hygiene, 86(5), 745–752. https://doi.org/10.4269/ajtmh.2012.11-0784
  6. Islammia, D.P.A., Rumana, N. A., Indawati, L., & Dewi, D. R. (2022). Karakteristik Pasien Demam Berdarah Dengue Rawat Inap di Rumah Sakit Umum UKI Tahun 2020. SEHATMAS: Jurnal Ilmiah Kesehatan Masyarakat, 1(1), 60–70. https://doi.org/10.55123/sehatmas.v1i1.37
  7. Kemenkes RI. (2013) Pedoman Penerapan Kajian Farmakoekonomi. Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan. Jakarta: Kementerian Kesehatan Republik Indonesia.
  8. Kemenkes RI (2020). Pedoman Nasional Pelayanan Kedokteran Tata Laksana Infeksi Dengue pada Pasien Dewasa. Jakarta: Kementerian Kesehatan Republik Indonesia.
  9. Kemenkes RI (2021). Informasi Singkat DBD 2021 Germas. Jakarta: Kementerian Kesehatan Republik Indonesia.
  10. Kemenkes RI (2023). Informasi Dengue 2023. Jakarta: Kementerian Kesehatan Republik Indonesia.
  11. Lee, J. S., Mogasale, V., Lim, J. K., Carabali, M., Sirivichayakul, C., Anh, D. D., Lee, K. S., Thiem, V. D., Limkittikul, K., Tho, L. H., Velez, I. D., Osorio, J. E., Chanthavanich, P., da Silva, L. J., & Maskery, B. A. (2015). A multi-country study of the household willingness-to-pay for dengue vaccines: Household surveys in Vietnam, Thailand, and Colombia. PLoS Neglected Tropical Diseases, 9(6), 1–15. https://doi.org/10.1371/journal.pntd.0003810
  12. Martelli, C. M. T., Nascimento, N. E., Suaya, J. A., Siqueira, J. B., Souza, W. V., Turchi, M. D., Guilarde, A. O., Peres, J. B., & Shepard, D. S. (2011). Quality of life among adults with confirmed dengue in Brazil. American Journal of Tropical Medicine and Hygiene, 85(4), 732–738. https://doi.org/10.4269/ajtmh.2011.11-0067
  13. Nadjib, M. (2019). The Economic Burden of Dengue in Indonesia. International Pest Control, 61(2), 90–91. https://doi.org/10.1371/journal.pntd.0007038
  14. Prasetyani, D. R. (2015). Faktor-Faktor Yang berhubungan Dengan Kejadian Demam Berdarah Dengue. Majority., 4(7).
  15. Ramadani, F., Azizah, N., Ayu, S. M., & Lubis, T. T. (2023). Hubungan Karakteristik Penderita Demam Berdarah Dengue di Rumah Sakit Haji Medan Periode Januari-Juni 2022. Jurnal Kedokteran dan Kesehatan-Fakultas Kedokteran Universitas Islam Sumatera Utara, 22(2), 189-195. https://doi.org/10.30743/ibnusina.v22i2.498
  16. Ratnawiningsih, H., Perwitasari, D. A., Supadmi, W., & Faridah, I. N. (2022). Kualitas Hidup dan Biaya Sakit Pasien Dengue di Rumah Sakit PKU Muhammadiyah Bantul Yogyakarta. Majalah Farmaseutik, 18(1), 1-7. https://doi.org/10.22146/farmaseutik.v18i1.70539
  17. Rohman, H., & Susilowati, E. (2020). Analisis Perbedaan Biaya Pasien Demam Berdarah Dengue dengan dan Tanpa Clinical Pathway di Rumah Sakit Condong Catur. Prosiding: Seminar Manajemen Informasi Kesehatan Nasional dan Call for Paper, 47–53.
  18. Sari, A., Yuni Lestari, N., & Aryani Perwitasari, D. (2015). Validasi ST European Quality OF Life-5 Dimensions (EQ-5D) Versi Indonesia Pada Pasien Hipertensi Di Puskesmas Kotagede II Yogyakarta. Pharmaciana, 5(2). https://doi.org/10.12928/pharmaciana.v5i2.2483
  19. Sihite, E. W., Mahendradata, Y., & Baskoro, T. (2017). Beban Biaya Penyakit Demam Berdarah Dengue di Rumah Sakit dan Puskesmas Cost Burden of Dengue Hemorrhagic Fever in Hospitals and Public Health Centers. Berita Kedokteran Masyarakat (BKM Journal of Community Medicine and Public Health, 33(7), 375–364. https://doi.org/10.22146/bkm.13699
  20. Sumaryati, M., Rosmiati, & Wasilah. (2019). Studi Kasus pada Pasien Demam Berdarah Dengue. Jurnal Ilmiah Kesehatan Sandi Husada, 10(2), 51-56. https://doi.org/10.35816/jiskh.v10i2.106
  21. van Reenen, M., Janssen, B., Oppe, M., Kreimeier, S., Greiner, W., Stolk, E., Secnik Boye, K., Herdman, M., Kennedy-Martin, M., Kennedy-Martin, T., & Slaap, B. (2015). CHANGES INCLUDED in this update of the EQ-5D-Y User Guide Table of contents: Vol. 2.1 (2nd ed.). EuroQol Research Foundation. Available from www.euroqol.org
  22. van Reenen, M. V., Janssen, B., Stolk, E., Boye, K. S., Herdman, M., Kennedy-Martin, M., Kennedy-Martin, T., & Slaap, B. (2019). EQ-5D User Guide Basic Information on How to Use the EQ-5D-5L Instrument Version 3.0. The Netherland: EueoQol Research Foundation, 36.
  23. WHO. (2011). Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Hemorrhagic Fever. World Health Organization Regional Office for South-East Asia.
  24. WHO. (2023). Dengue and Severe Dengue. World Health Organization.
  25. Wilastonegoro, N. N., Kharisma, D. D., Laksono, I. S., Halasa-Rappel, Y. A., Brady, O. J., & Shepard, D. S. (2020). Cost of Dengue Illness in Indonesia Across Hospital, Ambulatory, and not Medically Attended Settings. American Journal of Tropical Medicine and Hygiene, 103(5), 2029–2039. https://doi.org/10.4269/ajtmh.19-0855

Most read articles by the same author(s)